Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.
Osteopontin-stimulated expression of matrix metalloproteinase-9 causes cardiomyopathy in the mdx model of Duchenne muscular dystrophy.
复制标题
DOI:
10.4049/jimmunol.1101342
复制
发表时间:
2011-09-01
期刊:
影响因子:
--
通讯作者:
Kumar A
中科院分区:
文献类型:
--
作者:
Dahiya S;Givvimani S;Bhatnagar S;Qipshidze N;Tyagi SC;Kumar A
Duchenne muscular dystrophy (DMD), caused by mutations in the dystrophin gene, is a common and lethal form of muscular dystrophy. With progressive disease, most patients succumb to death from respiratory and/or heart failure. However, the mechanisms, especially those governing cardiac inflammation and fibrosis in DMD, remain less well understood. Matrix metalloproteinase (MMPs) are a group of extracellular matrix proteases involved in tissue remodelling in both physiological and pathophysiological conditions. Previous studies have shown that MMP-9 exacerbates myopathy in dystrophin-deficient mdx mice. However, the role and the mechanisms of action of MMP-9 in cardiac tissue and the biochemical mechanisms leading to increased levels of MMP-9 in mdx mice remain unknown. Our results demonstrate that the levels of MMP-9 are increased in heart of mdx mice. Genetic ablation of MMP-9 attenuated cardiac injury, left ventricle dilation, and fibrosis in one-year old mdx mice. Echocardiography measurements showed improved heart function in Mmp9-deficient mdx mice. Deletion of Mmp9 gene diminished the activation of extracellular-regulated kinase ½ and Akt kinase in heart of mdx mice. Ablation of MMP-9 also suppressed the expression of MMP-3 and MMP-12 in heart of mdx mice. Finally, our experiments have revealed that osteopontin, an important immunomodulator, contributes to the increased amounts of MMP-9 in cardiac and skeletal muscle of mdx mice. This study provides a novel mechanism for development of cardiac dysfunction and suggests that MMP-9 and OPN are important therapeutic targets to mitigating cardiac abnormalities in DMD patients.
登录
查看更多内容
影响因子:
4.7
作者:
Bhatnagar, Shephali;Kumar, Ashok
通讯作者:
Kumar, Ashok
DOI:
10.1161/atvbaha.110.219147
发表时间:
2011-03
期刊:
Arteriosclerosis, thrombosis, and vascular biology
影响因子:
--
作者:
Johnson JL;Devel L;Czarny B;George SJ;Jackson CL;Rogakos V;Beau F;Yiotakis A;Newby AC;Dive V
通讯作者:
Dive V
DOI:
10.4049/jimmunol.0803357
发表时间:
2009-02-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
作者:
Kumar M;Makonchuk DY;Li H;Mittal A;Kumar A
通讯作者:
Kumar A
DOI:
10.1073/pnas.0506201102
发表时间:
2005-10-25
影响因子:
11.1
作者:
Johnson, JL;George, SJ;Jackson, CL
通讯作者:
Jackson, CL
影响因子:
6
作者:
Hnia, Karim;Gayraud, Jerome;Mornet, Dominique
通讯作者:
Mornet, Dominique